MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 228 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,453,426 | +452.6% | 1,845,330 | +690.8% | 0.02% | +450.0% |
| Q4 2022 | $3,339,293 | -49.5% | 233,355 | -10.0% | 0.00% | -55.6% |
| Q3 2022 | $6,619,000 | +2.8% | 259,261 | +14.4% | 0.01% | +12.5% |
| Q2 2022 | $6,440,000 | -64.1% | 226,667 | -55.4% | 0.01% | -55.6% |
| Q1 2022 | $17,928,000 | +128.4% | 508,313 | +171.4% | 0.02% | +125.0% |
| Q4 2021 | $7,849,000 | +72.9% | 187,319 | +102.6% | 0.01% | +60.0% |
| Q3 2021 | $4,539,000 | -59.0% | 92,478 | -65.2% | 0.01% | -58.3% |
| Q2 2021 | $11,084,000 | +143.8% | 265,605 | +108.2% | 0.01% | +100.0% |
| Q1 2021 | $4,547,000 | – | 127,575 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |